Division of Endocrinology, Department of Internal Medicine, University of Texas Medical Branch, Galveston.
Bay Area Metabolic Health, Houston, Texas.
Gastroenterology. 2017 May;152(7):1647-1655. doi: 10.1053/j.gastro.2017.01.046. Epub 2017 Feb 10.
The prospect of a significant increase in global health-related costs associated with high cardiometabolic complications of obesity in Asians has encouraged more attention to be focused on the problem of growing obesity prevalence in these populations. Although these studies have shown that cardiometabolic complications occur more frequently and at a lower body mass index (BMI) in Asians than in European populations, the mechanisms involved have yet to be discovered. Ethnic/racial differences in body composition and fat distribution have been studied extensively. Although these studies have shown that increasing BMI is associated with larger increases in body fat content in Asians, growing evidence points to factors other than body fat content and fat distribution in determining a higher prevalence of cardiometabolic complications in these populations. Here, we provide support to our view that earlier onset of adipocyte maturation arrest/insulin resistance during weight gain could be a major factor in increasing the cardiometabolic risk of Asian populations at a lower BMI.
与亚洲人群肥胖相关的心血管代谢并发症相关的全球卫生成本显著增加的前景,促使人们更加关注这些人群中日益增长的肥胖患病率这一问题。尽管这些研究表明,与欧洲人群相比,亚洲人群的心血管代谢并发症更频繁地发生,且 BMI 更低,但涉及的机制尚未被发现。人体成分和脂肪分布的种族/民族差异已被广泛研究。尽管这些研究表明,BMI 的增加与亚洲人体内体脂肪含量的更大增加有关,但越来越多的证据表明,除了体脂肪含量和脂肪分布外,还有其他因素决定了这些人群中心血管代谢并发症的更高患病率。在这里,我们支持这样一种观点,即在体重增加期间,脂肪细胞成熟阻滞/胰岛素抵抗的早期发生可能是导致亚洲人群 BMI 较低时心血管代谢风险增加的一个主要因素。